News
Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) ...
President Donald Trump’s administration is slated to lay out its approach to Covid vaccination at an event Tuesday that could spell major changes in what is required to get regulatory approval for ...
The U.S. Food and Drug Administration (FDA) has granted full approval to Novavax's COVID-19 vaccine, but only for certain ...
The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...
The FDA has approved Novavax’s COVID-19 vaccine, Nuvavoxid, for use in adults 65 and older and in individuals ages 12-64 who have at least one underlying health condition. The approval is based on ...
Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...
Novavax had expected full approval for broader use by April 1, after the FDA reviewed data from a 30,000-person clinical ...
The Food and Drug Administration will soon “unleash a massive framework” for how vaccines are tested and approved.
Novavax received Food and Drug Administration approval for its new, protein-based COVID-19 vaccine, and shares jumped 25% at the opening bell Monday.
Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...
The House Judiciary Committee revealed Thursday that Pfizer’s former Global Head of Vaccines Research and Development, Dr.
The GOP-led House Judiciary Committee is investigating allegations that Pfizer delayed its COVID-19 vaccine testing until ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results